Search

Your search keyword '"Debeaupuis, Emilie"' showing total 10 results
Start Over Author "Debeaupuis, Emilie"
10 results on '"Debeaupuis, Emilie"'

1. Omission of lymphadenectomy in patients with advanced epithelial ovarian cancer treated with primary or interval cytoreductive surgery after neoadjuvant chemotherapy: The CARACO phase III randomized trial.

Author

Classe, Jean-Marc, primary, Campion, Loic, additional, Lecuru, Fabrice, additional, Vergote, Ignace, additional, Jankowski, Clémentine, additional, Wernert, Romuald, additional, Pomel, Christophe, additional, Houvenaeghel, Gilles, additional, Dupre, Pierre-Francois, additional, Mathevet, Patrice, additional, Villet, Richard, additional, Joly, Florence, additional, Berton, Dominique, additional, Debeaupuis, Emilie, additional, Frenel, Jean-Sebastien, additional, and Loaec, Cecile, additional

Published
2024
Full Text
View/download PDF

3. Preliminary results of a 68Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making

Author

Rousseau, Caroline, primary, Le Thiec, Maelle, additional, Ferrer, Ludovic, additional, Rusu, Daniela, additional, Rauscher, Aurore, additional, Maucherat, Bruno, additional, Frindel, Mathieu, additional, Baumgartner, Pierre, additional, Fleury, Vincent, additional, Denis, Antoine, additional, Morel, Agnes, additional, Varmenot, Nicolas, additional, Debeaupuis, Emilie, additional, Campion, Loic, additional, and Kraeber‐Bodéré, Francoise, additional

Published
2019
Full Text
View/download PDF

4. Preliminary results of a 68Ga‐PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision‐making.

Author

Rousseau, Caroline, Le Thiec, Maelle, Ferrer, Ludovic, Rusu, Daniela, Rauscher, Aurore, Maucherat, Bruno, Frindel, Mathieu, Baumgartner, Pierre, Fleury, Vincent, Denis, Antoine, Morel, Agnes, Varmenot, Nicolas, Debeaupuis, Emilie, Campion, Loic, and Kraeber‐Bodéré, Francoise

Published
2019
Full Text
View/download PDF

8. Structural bases for the selection of a public TCR against the HCMV NLV epitope

Author

Reiser, Jean-Baptiste, primary, Gras, Stéphanie, additional, Saulquin, Xavier, additional, Debeaupuis, Emilie, additional, Echasserieau, Klara, additional, Kissenpfennig, Adrien, additional, Legoux, François, additional, Chouquet, Anne, additional, Le Gorrec, Madalen, additional, Machillot, Paul, additional, Neveu, Bérangère, additional, Thielens, Nicole, additional, Malissen, Bernard, additional, Bonneville, Marc, additional, and Housset, Dominique, additional

Published
2009
Full Text
View/download PDF

9. Structural Bases for the Affinity-Driven Selection of a Public TCR against a Dominant Human Cytomegalovirus Epitope

Author

Gras, Stéphanie, primary, Saulquin, Xavier, additional, Reiser, Jean-Baptiste, additional, Debeaupuis, Emilie, additional, Echasserieau, Klara, additional, Kissenpfennig, Adrien, additional, Legoux, François, additional, Chouquet, Anne, additional, Le Gorrec, Madalen, additional, Machillot, Paul, additional, Neveu, Bérangère, additional, Thielens, Nicole, additional, Malissen, Bernard, additional, Bonneville, Marc, additional, and Housset, Dominique, additional

Published
2009
Full Text
View/download PDF

10. Preliminary results of a 68 Ga-PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision-making.

Author

Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, Frindel M, Baumgartner P, Fleury V, Denis A, Morel A, Varmenot N, Debeaupuis E, Campion L, and Kraeber-Bodéré F

Subjects
Aged, Decision Making, Female, Gallium Isotopes, Gallium Radioisotopes, Humans, Kallikreins blood, Male, Middle Aged, Neoplasm Recurrence, Local blood, Positron Emission Tomography Computed Tomography methods, Prospective Studies, Prostate-Specific Antigen blood, Prostatic Neoplasms blood, Membrane Glycoproteins, Neoplasm Recurrence, Local diagnostic imaging, Neoplasm Recurrence, Local therapy, Organometallic Compounds, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms therapy, Radiopharmaceuticals
Abstract

Background: In this prospective study (NCT03443609), we investigated the impact of 68Ga-PSMA-11 PET-CT on the treatment plan and therapeutic response obtained for patients with prostate cancer (PCa) presenting a recurrence with a low rising PSA., Methods: One hundred thirty hormone-naive (PSA < 1.5 ng/mL) patients were enrolled. All patients received radical treatment. PET images were recorded 1 and 2  hours after injection of tracer and interpreted by two independent nuclear physicians. Six months after treatment ended, a PSA assay was requested to evaluate the therapeutic efficacy of the treatment based on PSMA results., Results: Data analysis for the first 52 included patients has been completed. 68Ga-PSMA-11-positive lesions were detected in 38/52 (73.1%) patients. Ninety-four lesions were detected as follows, 53/94 in lymph nodes (56.4%), 25/94 in bone (26.6%), and 12/94 into the prostate bed (12.7%). Detection rates were 58%, 81%, and 82% for serum PSA levels lower than 0.25 ng/mL, between 0.25 to ≤ 0.69  ng/mL and 0.70  ng/mL, respectively. As a result of the PSMA PET-CT, therapeutic management changed in 38/52 patients (73.1%). Patients had undetectable serum PSA levels after treatment guided by 68Ga-PSMA-11 PET-CT results in 10/52 (19.2%) cases and with a PSA decrease of over 60% in 18/52 (34.6%) patients., Conclusion: Whilst our patient population presented a very low PSA level, preliminary results of the 68Ga-PSMA PET-CT study showed recurrence localization in more than half of the patients and this had a major clinical impact, as it resulted in treatment change in more than half of the patients and a significant decrease in PSA levels in a third of patients., (© 2019 Wiley Periodicals, Inc.)

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results